Research on the human microbiome and interest in alternative medicine have led to funding for Viome, a startup that assesses customers’ microbiomes and provides personalized supplements and guidance. The company, which has raised $86.5 million in a Series C funding round, uses AI and RNA sequencing technology to analyze biological samples and offer recommendations. Viome plans to expand its business, including new product lines and retail partnerships. However, skeptics, including scientists in the field, question the company’s claims and the ability to translate microbiome research into conclusive treatments.
Meta Data: {“keywords”:”Viome, microbiome research, alternative medicine”}
Source link